Akura Medical

Our CEO?Murali Srivathsa?will be sharing the Akura Medical story on Thursday, March 20 at 4:40 pm (Track 4) at #LSIUSA25. Learn more about how Akura's?flagship product, the Katana? Thrombectomy System, is poised to redefine pulmonary embolism (PE) treatment standards by enabling enhanced removal of diverse clot types without clogging, optimizing catheter delivery, and providing supplementary intraoperative feedback. ?????? ???????????? ???????????????????????? ???????????? ???? ?????? ?????????????????????????????? ?????? ???????? ?????? ???? ?????? ?????? ???????? ???? ?????? ??.??. ???? ?????????????? ?????? ??.??. #VTE #thrombectomy #innovation #medtech

We're looking forward to LSI USA 2025 this week! Join Akura Medical CEO?Murali Srivathsa?as he discusses?Shifamed's?approach?to medical device innovation with?Tioga Cardiovascular?CEO?Mike Dineen?and?Atia Vision CEO?Mariam Maghribi.?The panel discussion, led by?Joe Mullings of The Mullings Group,?will cover Shifamed's key ingredients for building successful Medtech ventures, including capital efficiency, technology differentiation, and market positioning.?The session takes place tomorrow, March 18th from 12:20 to 12:50 pm.?Don't miss it! #LSIUSA25 #VTE #thrombectomy #innovation #medtech

"When designing the Katana Thrombectomy System, the tortuosity of the anatomy was at the forefront of the design considerations.” Hear from our co-founder and VP of R&D Aadel Al-Jadda and?engineer Paul Gunning?about how the Katana system aims to help physicians quickly navigate to the clot location. ?????? ???????????? ???????????????????????? ???????????? ???? ?????? ?????????????????????????????? ?????? ???????? ?????? ???? ?????? ?????? ???????? ???? ?????? ??.??. ???? ?????????????? ?????? ??.??. #thrombectomy #VTE #innovation #medtech?#cardiovascular #innovation

Thank you LSI for the invitation! We look forward to sharing how Akura Medical is poised to make a difference for patients suffering from venous thromboembolism at #LSIUSA25. #VTE #thrombectomy #innovation #medtech

#DYK: Venous thromboembolism (or blood clots in the veins) is the #3 leading cause of cardiovascular death and impacts ~900k people each year? Join the Akura Medical team as we work to raise awareness about the impact of VTE this Blood Clot Awareness Month. The Katana Thrombectomy System is for investigational use only and is not for sale in the U.S. or outside the U.S. #BCAM2025 #bloodclotawareness?#VTE #thrombectomy #innovation #medtech?#cardiovascular

What is Hydro Blade technology and how does it work against clots of different morphologies? Watch our new video to learn more about the innovation behind Hydro Blade technology and the role it plays in the Katana Thrombectomy System. The Katana Thrombectomy System is for investigational use only and is not for sale in the U.S. or outside the U.S. #thrombectomy #VTE #innovation #medtech?#cardiovascular #innovation

“The Katana Thrombectomy System is a result of a lot of market research and understanding the needs of the market by speaking with our physicians." Watch our latest video to learn more about the purposeful design behind the Katana Thrombectomy System. https://lnkd.in/g3-AWSEX The Katana Thrombectomy System is for investigational use only and is not for sale in the U.S. or outside the U.S. #thrombectomy #VTE #innovation #medtech #cardiovascular #innovation

The Akura Medical team was honored to host Dr. Mahmood Razavi on #WearRedDay. We appreciated Dr. Razavi's insights as he shared his perspectives on venous thromboembolism, currently available treatment options and how the work we're doing has the potential to make a difference for VTE patients in the future. #heartmonth?#GoRedforWomen?#innovation #thrombectomy #VTE #medtech

BREAKING NEWS - Akura Medical is pleased to announce the first patient treated in its QUADRA-PE IDE study for pulmonary embolism. Thank you to Dr. Samuel Horr, MD and the TriStar Centennial Medical Center team for their help in achieving this important milestone. We look forward to enrolling more patients and expanding to additional sites. Read the full press release here: https://lnkd.in/gKTShFFi The Katana Thrombectomy System is for investigational use only and is not for sale in the U.S. or outside the U.S. #QUADRAPE #thrombectomy #VTE #innovation #medtech?#cardiovascular

Our CEO Murali Srivathsa sat down with Joe Mullings to discuss what makes the Katana Thrombectomy System different, recent milestones, and what’s on the horizon for 2025. Thank you Joe for the opportunity to share our story! The Katana Thrombectomy System is for investigational use only and is not for sale in the U.S. or outside the U.S. #thrombectomy #VTE #innovation #medtech #cardiovascular